시장보고서

상품코드

1652109

세계의 원격약국 시장 규모, 점유율, 동향, 업계 분석 : 유형별, 컴포넌트별, 제공 방식별, 디바이스별, 용도별, 지역별 - 예측(2025-2034년)

Telepharmacy Market Size, Share, Trends, Industry Analysis Report: By Type, Component, Delivery Mode, Devices, Application, and Region - Market Forecast, 2025-2034

발행일: 2025년 01월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 원격약국 시장 규모는 2034년까지 689억 8,000만 달러에 달할 전망입니다. 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

원격약국은 원격 통신 기술을 통해 의약품 서비스를 제공하는 것으로, 약사가 직접 대면하지 않고도 상담, 조제, 기타 의약품 관리 서비스를 제공할 수 있습니다.

원격 약국 시장은 특히 의료 서비스가 부족한 지역과 농촌 지역에서 원격의료 서비스에 대한 수요가 증가함에 따라 크게 성장하고 있습니다. 다른 주요 시장 성장 촉진요인으로는 원격의료의 확대, 클라우드 기반 및 AI 기술의 발전, 효율적인 약물 관리에 대한 수요 증가 등이 있습니다. 또한 특히 COVID-19 팬데믹 이후 원격 약수처리 서비스의 광범위한 채택을 가능하게 하는 규제 변경도 시장을 지원하고 있습니다.

원격약국 시장 기회는 요양원, 교도소, 군부대 등 기존과는 다른 환경으로의 서비스 확대에 있습니다. 현재 추세는 모바일 헬스 통합의 부상, 원격 조제 자동화, 개인화된 환자 관리를 위한 디지털 플랫폼의 채택 등을 들 수 있습니다. 의료 서비스 프로바이더들이 환자의 접근성, 안전성, 복약 순응도를 향상시키기 위해 디지털 솔루션을 채택하는 사례가 증가함에 따라 원격약국슈티컬 시장은 지속적으로 성장할 것으로 예상됩니다.

원격약국 시장 : 분석 개요

유형별로는 원격 조제 분야가 시장을 주도하고 있으며, 특히 농어촌 및 서비스 소외지역에서 접근성 높은 의약품 배송에 대한 수요가 증가하고 있는 것이 그 배경입니다. 또한 원격의료 도입 증가와 효율적인 의약품 서비스의 필요성으로 인해 가장 높은 성장을 기록하고 있습니다.

컴포넌트별로는 효율적인 투약 관리와 원격 상담을 가능하게 하는 통합형 원격약국 플랫폼에 대한 수요 증가에 힘입어 소프트웨어 분야가 가장 큰 원격약국 시장 점유율을 차지하고 있습니다. 또한 클라우드 기반의 기술 혁신과 AI로 인해 가장 높은 성장세를 보이고 있습니다.

제공 방식별로는 클라우드 기반 부문이 시장 점유율과 성장률에서 선두를 달리고 있으며, 유연성, 확장성, 비용 효율성을 제공하며 원격 약국 보급에 필수적인 역할을 하고 있습니다. 또한 의료 서비스에서 클라우드 기술이 통합되고 있는 것도 성장을 가속화하고 있습니다.

기기별로는 스마트폰/태블릿 단말기 분야가 가장 큰 비중을 차지하고 있으며, 이는 원격 약국에서의 약물 상담 및 처방 관리 등 의료 서비스 접근에 있으며, 모바일 기기에 대한 의존도가 높아지고 있기 때문입니다. 또한 이 부문은 모바일 헬스 앱의 보급으로 가장 빠르게 성장하고 있습니다.

용도별로는 병원이 원격약국 시장에서 가장 큰 비중을 차지하고 있으며, 첨단 의료 인프라와 광범위한 병원 시스템에 원격약국 솔루션의 통합을 통해 혜택을 누리고 있습니다. 소규모 약국 부문은 약국들이 점점 더 많은 약국들이 원격약국 솔루션을 채택하여 범위를 확장함에 따라 가장 높은 성장세를 보이고 있습니다.

북미는 탄탄한 의료 인프라, 광범위한 원격의료 도입, 강력한 규제 지원을 바탕으로 세계 시장을 장악하고 있습니다. 아시아태평양의 텔레파시 시장은 인도, 중국, 일본과 같은 국가들의 의료 수요 증가와 빠른 디지털 의료 도입에 힘입어 가장 높은 성장세를 보이고 있습니다.

이 시장의 주요 기업에는 Teladoc Health, Pharmalink, MedPharm, Cerner Corporation, ScriptPro, TelePharm, MediSprout, PipelineRx, Pharmacy Automation Systems, Omnicare, Pharmasimple, Healthway Services, HealthHub, CVS Health, McKesson Corporation 등이 있습니다.

시장 스냅숏
원격약국 시장 역학
- 촉진요인과 기회
  - 원격의료 제공 모드의 채택
  - 인공지능(AI)과 기계학습(ML)의 통합
- 억제요인과 과제
  - 인터넷에 대한 높은 의존도
PESTLE 분석
원격약국 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 원격약국 시장 : 유형별

주요 조사 결과
서론
입원 환자
원격 조제
수액(IV) 혼합
원격 카운셀링

제6장 세계의 원격약국 시장 : 컴포넌트별

주요 조사 결과
서론
하드웨어
소프트웨어

제7장 세계의 원격약국 시장 : 제공 방식별

주요 조사 결과
서론
온프레미스
웹기반
클라우드 기반

제8장 세계의 원격약국 시장 : 디바이스별

주요 조사 결과
서론
컴퓨터
스마트폰
태블릿
키오스크

제9장 세계의 원격약국 시장 : 용도별

주요 조사 결과
서론
병원
소규모 약국
요양원
형무소
군 기지
군함

제10장 세계의 원격약국 시장 : 지역별

주요 분석 결과
서론
- 원격약국 시장 평가 : 지역별(2020-2034년)
북미
- 북미 : 유형별(2020-2034년)
- 북미 : 컴포넌트별(2020-2034년)
- 북미 : 제공 방식별(2020-2034년)
- 북미 : 디바이스별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 컴포넌트별(2020-2034년)
- 유럽 : 제공 방식별(2020-2034년)
- 유럽 : 디바이스별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 컴포넌트별(2020-2034년)
- 아시아태평양 : 제공 방식별(2020-2034년)
- 아시아태평양 : 디바이스별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 컴포넌트별(2020-2034년)
- 중동 및 아프리카 : 제공 방식별(2020-2034년)
- 중동 및 아프리카 : 디바이스별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 컴포넌트별(2020-2034년)
- 라틴아메리카 : 제공 방식별(2020-2034년)
- 라틴아메리카 : 디바이스별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제11장 경쟁 구도

사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
제휴/협업/합의/공개

제12장 기업 개요

Teladoc Health
Pharmalink
MedPharm
Cerner Corporation
ScriptPro
TelePharm
MediSprout
PipelineRx
Pharmacy Automation Systems
Omnicare

KSA 25.03.13

The global telepharmacy market size is expected to reach USD 68.98 billion by 2034, according to a new study by Polaris Market Research. The report "Telepharmacy Market Size, Share, Trends, Industry Analysis Report: By Type, Component (Hardware and Software), Delivery Mode, Devices, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Telepharmacy is the provision of pharmaceutical services through remote communication technologies, allowing pharmacists to offer consultations, medication dispensing, and other pharmaceutical care services without the need for in-person interactions.

The telepharmacy market is experiencing significant growth, driven by increasing demand for remote healthcare services, particularly in underserved and rural areas. Other key market drivers include the expansion of telemedicine, advancements in cloud-based and AI technologies, and the growing need for efficient medication management. The market is also supported by regulatory changes that allow for broader adoption of telepharmacy services, particularly after the COVID-19 pandemic.

Telephramacy market opportunities lie in expanding services to non-traditional settings such as nursing homes, prisons, and military bases. Current trends include the rise of mobile health integration, automation in remote dispensing, and the adoption of digital platforms for personalized patient care. Overall, the telepharmacy market is expected to continue growing as healthcare providers increasingly adopt digital solutions to improve patient access, safety, and medication adherence.

Key Highlights of Telepharmacy Market Report

Based on type, the remote dispensing segment dominates the market, driven by the increasing demand for accessible medication delivery, particularly in rural and underserved areas. It is also registering the highest growth due to the rise in telehealth adoption and the need for efficient pharmaceutical services.

Based on component, the software segment holds the largest telepharmacy market share, fueled by the growing demand for integrated telepharmacy platforms that enable efficient medication management and remote consultations. It is also seeing the highest growth, driven by innovations in cloud-based technology and AI.

By delivery mode, the cloud-based segment leads in market share and growth, offering flexibility, scalability, and cost-effectiveness, which are crucial for widespread telepharmacy adoption. Its growth is also accelerated by the increasing integration of cloud technology in healthcare services.

Based on devices, the smartphones and tablets segment holds the largest share, driven by the growing reliance on mobile devices for accessing healthcare services, including telepharmacy consultations and prescription management. This segment is also growing the fastest due to the widespread adoption of mobile health apps.

By application, hospitals represent the largest segment in the telepharmacy market, benefiting from advanced healthcare infrastructure and the integration of telepharmacy solutions into broader hospital systems. The small pharmacies segment is registering the highest growth as pharmacies increasingly adopt telepharmacy solutions to expand their reach.

North America dominates the global market, supported by robust healthcare infrastructure, widespread telehealth adoption, and strong regulatory support. The Asia Pacific telepharmacy market is experiencing the highest growth, driven by increasing healthcare demand and rapid digital healthcare adoption across countries like India, China, and Japan.

Some of the key players in the market include Teladoc Health, Pharmalink, MedPharm, Cerner Corporation, ScriptPro, TelePharm, MediSprout, PipelineRx, Pharmacy Automation Systems, Omnicare, Pharmasimple, Healthway Services, HealthHub, CVS Health, McKesson Corporation.

Polaris Market Research has segmented the telepharmacy market report on the basis of type, component, delivery mode, devices, application, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Inpatient
Remote Dispensing
IV Admixture
Remote Counselling

By Component Outlook (Revenue-USD Billion, 2020-2034)

Hardware
Software

By Delivery Mode Outlook (Revenue-USD Billion, 2020-2034)

On-Premises
Web-Based
Cloud-Based

By Devices Outlook (Revenue-USD Billion, 2020-2034)

Computers
Smartphones
Tablets
Kiosk

By Application Outlook (Revenue-USD Billion, 2020-2034)

Hospitals
Small Pharmacies
Nursing Home
Prisons
Military Base
War Ships

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Telepharmacy Market Insights

4.1. Telepharmacy Market - Devices Snapshot
4.2. Telepharmacy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Adoption of Telehealth Delivery Modes
  - 4.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High dependency on internet
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Telepharmacy Market Trends
4.6. Value Chain Analysis

5. Global Telepharmacy Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Telepharmacy Market, by Type, 2020-2034 (USD Billion)
5.3. Inpatient
- 5.3.1. Global Telepharmacy Market, Inpatient, by Region, 2020-2034 (USD Billion)
5.4. Remote Dispensing
- 5.4.1. Global Telepharmacy Market, by Remote Dispensing, by Region, 2020-2034 (USD Billion)
5.5. IV Admixture
- 5.5.1. Global Telepharmacy Market, by IV Admixture, by Region, 2020-2034 (USD Billion)
5.6. Remote Counselling
- 5.6.1. Global Telepharmacy Market, by Remote Counselling, by Region, 2020-2034 (USD Billion)

6. Global Telepharmacy Market, by Component

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Telepharmacy Market, by Component, 2020-2034 (USD Billion)
6.3. Hardware
- 6.3.1. Global Telepharmacy Market, by Hardware, by Region, 2020-2034 (USD Billion)
6.4. Software
- 6.4.1. Global Telepharmacy Market, by Software, by Region, 2020-2034 (USD Billion)

7. Global Telepharmacy Market, by Delivery Mode

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
7.3. On-Premises
- 7.3.1. Global Telepharmacy Market, by On-Premises, by Region, 2020-2034 (USD Billion)
7.4. Web-Based
- 7.4.1. Global Telepharmacy Market, Web-Based, by Region, 2020-2034 (USD Billion)
7.5. Cloud-Based
- 7.5.1. Global Telepharmacy Market, Cloud-Based, by Region, 2020-2034 (USD Billion)

8. Global Telepharmacy Market, by Devices

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
8.3. Computers
- 8.3.1. Global Telepharmacy Market, by Computers, by Region, 2020-2034 (USD Billion)
8.4. Smartphones
- 8.4.1. Global Telepharmacy Market, by Smartphones, by Region, 2020-2034 (USD Billion)
8.5. Tablets
- 8.5.1. Global Telepharmacy Market, by Tablets, by Region, 2020-2034 (USD Billion)
8.6. Kiosk
- 8.6.1. Global Telepharmacy Market, by Kiosk, by Region, 2020-2034 (USD Billion)

9. Global Telepharmacy Market, by Application

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Telepharmacy Market, by Application, 2020-2034 (USD Billion)
9.3. Hospitals
- 9.3.1. Global Telepharmacy Market, by Hospitals, by Region, 2020-2034 (USD Billion)
9.4. Small Pharmacies
- 9.4.1. Global Telepharmacy Market, by Small Pharmacies, by Region, 2020-2034 (USD Billion)
9.5. Nursing Home
- 9.5.1. Global Telepharmacy Market, by Nursing Home, by Region, 2020-2034 (USD Billion)
9.6. Prisons
- 9.6.1. Global Telepharmacy Market, by Prisons, by Region, 2020-2034 (USD Billion)
9.7. Military Base
- 9.7.1. Global Telepharmacy Market, by Military Base, by Region, 2020-2034 (USD Billion)
9.8. Warship
- 9.8.1. Global Telepharmacy Market, by Warship, by Region, 2020-2034 (USD Billion)

10. Global Telepharmacy Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Telepharmacy Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. Telepharmacy Market - North America
- 10.3.1. North America: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
- 10.3.3. North America: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
- 10.3.4. North America: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
- 10.3.5. North America: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.3.7. Telepharmacy Market - U.S.
  - 10.3.7.1. U.S.: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.3.7.2. U.S.: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.3.7.3. U.S.: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.3.7.4. U.S.: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.3.7.5. U.S.: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.3.8. Telepharmacy Market - Canada
  - 10.3.8.1. Canada: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.3.8.2. Canada: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.3.8.3. Canada: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.3.8.4. Canada: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.3.8.5. Canada: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
10.4. Telepharmacy Market - Europe
- 10.4.1. Europe: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
- 10.4.3. Europe: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
- 10.4.4. Europe: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
- 10.4.5. Europe: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.6. Telepharmacy Market - UK
  - 10.4.6.1. UK: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.7. Telepharmacy Market - France
  - 10.4.7.1. France: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.8. Telepharmacy Market - Germany
  - 10.4.8.1. Germany: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.9. Telepharmacy Market - Italy
  - 10.4.9.1. Italy: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.10. Telepharmacy Market - Spain
  - 10.4.10.1. Spain: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.11. Telepharmacy Market - Netherlands
  - 10.4.11.1. Netherlands: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.12. Telepharmacy Market - Russia
  - 10.4.12.1. Russia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.4.13. Telepharmacy Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
10.5. Telepharmacy Market - Asia Pacific
- 10.5.1. Asia Pacific: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.6. Telepharmacy Market - China
  - 10.5.6.1. China: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.7. Telepharmacy Market - India
  - 10.5.7.1. India: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.8. Telepharmacy Market - Malaysia
  - 10.5.8.1. Malaysia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.9. Telepharmacy Market - Japan
  - 10.5.9.1. Japan: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.10. Telepharmacy Market - Indonesia
  - 10.5.10.1. Indonesia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.11. Telepharmacy Market - South Korea
  - 10.5.11.1. South Korea: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.12. Telepharmacy Market - Australia
  - 10.5.12.1. Australia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.5.13. Telepharmacy Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
10.6. Telepharmacy Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.6.6. Telepharmacy Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.6.7. Telepharmacy Market - UAE
  - 10.6.7.1. UAE: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.6.8. Telepharmacy Market - Israel
  - 10.6.8.1. Israel: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.6.9. Telepharmacy Market - South Africa
  - 10.6.9.1. South Africa: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.6.10. Telepharmacy Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
10.7. Telepharmacy Market - Latin America
- 10.7.1. Latin America: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.7.6. Telepharmacy Market - Mexico
  - 10.7.6.1. Mexico: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.7.7. Telepharmacy Market - Brazil
  - 10.7.7.1. Brazil: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.7.8. Telepharmacy Market - Argentina
  - 10.7.8.1. Argentina: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Telepharmacy Market, by Application, 2020-2034 (USD Billion)
- 10.7.9. Telepharmacy Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Telepharmacy Market, by Type, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Telepharmacy Market, by Component, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Telepharmacy Market, by Delivery Mode, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Telepharmacy Market, by Devices, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Telepharmacy Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Teladoc Health
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Pharmalink
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. MedPharm
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Cerner Corporation
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. ScriptPro
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. TelePharm
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. MediSprout
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. PipelineRx
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Pharmacy Automation Systems
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Omnicare
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development